These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33268847)

  • 1. Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer.
    Tapial S; García JL; Corchete L; Holowatyj AN; Pérez J; Rueda D; Urioste M; González-Sarmiento R; Perea J
    Eur J Hum Genet; 2021 Apr; 29(4):709-713. PubMed ID: 33268847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
    Augustus GJ; Xicola RM; Llor X; Ellis NA
    Genes Chromosomes Cancer; 2020 Aug; 59(8):454-464. PubMed ID: 32293075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.
    Melcher R; Hartmann E; Zopf W; Herterich S; Wilke P; Müller L; Rosler E; Kudlich T; Al-Taie O; Rosenwald A; Katzenberger T; Scholtka B; Seibold S; Rogoll D; Scheppach W; Scheurlen M; Lührs H
    Carcinogenesis; 2011 Apr; 32(4):636-42. PubMed ID: 21297112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining synchronous colorectal cancers based on tumor clonality.
    Perea J; García JL; Corchete L; Lumbreras E; Arriba M; Rueda D; Tapial S; Pérez J; Vieiro V; Rodríguez Y; Brandáriz L; García-Arranz M; García-Olmo D; Goel A; Urioste M; Sarmiento RG
    Int J Cancer; 2019 Apr; 144(7):1596-1608. PubMed ID: 30151896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
    Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
    Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
    Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of synchronous colorectal cancers in Japan.
    Kato T; Alonso S; Muto Y; Noda H; Miyakura Y; Suzuki K; Tsujinaka S; Saito M; Perucho M; Rikiyama T
    World J Surg Oncol; 2016 Oct; 14(1):272. PubMed ID: 27776528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH results.
    Hemmat M; Chen W; Anguiano A; Naggar ME; Racke FK; Jones D; Wang Y; Strom CM; Chang K; Boyar FZ
    Mol Cytogenet; 2014; 7():35. PubMed ID: 25177364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity pattern.
    Cheung KJ; Rogic S; Ben-Neriah S; Boyle M; Connors JM; Gascoyne RD; Horsman DE
    Cytogenet Genome Res; 2012; 136(1):38-43. PubMed ID: 22104078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss of heterozygosity on chromosome 3 in sporadic colorectal carcinoma].
    Peng Z; Ling Y; Bai S
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(6):336-9. PubMed ID: 11798895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous colorectal carcinoma: predisposing factors and characteristics.
    Chin CC; Kuo YH; Chiang JM
    Colorectal Dis; 2019 Apr; 21(4):432-440. PubMed ID: 30578740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common habitual behaviors and synchronous colorectal cancer risk: a retrospective case-control study.
    Kuo YH; Hung HY; You JF; Chiang JM; Chin CC
    Int J Colorectal Dis; 2019 Aug; 34(8):1421-1430. PubMed ID: 31278528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.
    van Puijenbroek M; Middeldorp A; Tops CM; van Eijk R; van der Klift HM; Vasen HF; Wijnen JT; Hes FJ; Oosting J; van Wezel T; Morreau H
    Fam Cancer; 2008; 7(4):319-30. PubMed ID: 18415027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
    González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
    Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome.
    Yang LP; Jiang TJ; He MM; Ling YH; Wang ZX; Wu HX; Zhang Z; Xu RH; Wang F; Yuan SQ; Zhao Q
    Cell Rep Med; 2023 Oct; 4(10):101222. PubMed ID: 37794586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of a patient with quadruple synchronous colorectal cancer: a case report.
    Jia X; Peng X; Sun J; Zhang T; Lin H; Bai T; Zhang A
    BMC Gastroenterol; 2021 Oct; 21(1):360. PubMed ID: 34600484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
    Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
    J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.
    Hänninen UA; Wirta EV; Katainen R; Tanskanen T; Hamberg J; Taipale M; Böhm J; Renkonen-Sinisalo L; Lepistö A; Forsström LM; Pitkänen E; Palin K; Seppälä TT; Mäkinen N; Mecklin JP; Aaltonen LA
    Br J Cancer; 2019 Apr; 120(9):922-930. PubMed ID: 30894686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes.
    Cheung KJ; Delaney A; Ben-Neriah S; Schein J; Lee T; Shah SP; Cheung D; Johnson NA; Mungall AJ; Telenius A; Lai B; Boyle M; Connors JM; Gascoyne RD; Marra MA; Horsman DE
    Genes Chromosomes Cancer; 2010 Aug; 49(8):669-81. PubMed ID: 20544841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.